Boston Scientific Corporation (BSX.F)
EUR 93.0
(4.49%)
EUR 93.0
(4.49%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 2.48 Billion USD | 33.05% |
| 2022 | 1.86 Billion USD | 15.96% |
| 2021 | 1.61 Billion USD | 19.17% |
| 2020 | 1.35 Billion USD | -14.44% |
| 2019 | 1.57 Billion USD | 35.42% |
| 2018 | 1.16 Billion USD | 8.16% |
| 2017 | 1.07 Billion USD | 12.88% |
| 2016 | 955 Million USD | -6.0% |
| 2015 | 1.01 Billion USD | 7.4% |
| 2014 | 946 Million USD | 5.46% |
| 2013 | 897 Million USD | 1.47% |
| 2012 | 884 Million USD | -5.05% |
| 2011 | 931 Million USD | 4.14% |
| 2010 | 894 Million USD | -2.83% |
| 2009 | 920 Million USD | 7.85% |
| 2008 | 853 Million USD | 17.66% |
| 2007 | 725 Million USD | -3.2% |
| 2006 | 749 Million USD | 79.19% |
| 2005 | 418 Million USD | 16.11% |
| 2004 | 360 Million USD | 28.11% |
| 2003 | 281 Million USD | 15.64% |
| 2002 | 243 Million USD | -19.8% |
| 2001 | 303 Million USD | -14.41% |
| 2000 | 354 Million USD | -5.85% |
| 1999 | 376 Million USD | -18.61% |
| 1998 | 462 Million USD | 19.47% |
| 1997 | 386.7 Million USD | 70.95% |
| 1996 | 226.2 Million USD | 56.0% |
| 1995 | 145 Million USD | 165.08% |
| 1994 | 54.7 Million USD | 30.86% |
| 1993 | 41.8 Million USD | 3.21% |
| 1992 | 40.5 Million USD | 12.19% |
| 1991 | 36.1 Million USD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 2.6 Billion USD | 1.84% |
| 2024 Q1 | 2.56 Billion USD | 3.1% |
| 2023 Q4 | 2.48 Billion USD | 3.33% |
| 2023 Q1 | 2.05 Billion USD | 9.8% |
| 2023 Q3 | 2.4 Billion USD | 6.84% |
| 2023 FY | 2.48 Billion USD | 33.05% |
| 2023 Q2 | 2.25 Billion USD | 9.76% |
| 2022 Q3 | 1.78 Billion USD | 2.05% |
| 2022 Q4 | 1.86 Billion USD | 4.42% |
| 2022 FY | 1.86 Billion USD | 15.96% |
| 2022 Q1 | 1.73 Billion USD | 7.83% |
| 2022 Q2 | 1.75 Billion USD | 0.92% |
| 2021 Q1 | 1.4 Billion USD | 4.15% |
| 2021 Q2 | 1.43 Billion USD | 1.63% |
| 2021 Q3 | 1.6 Billion USD | 12.1% |
| 2021 Q4 | 1.61 Billion USD | 0.44% |
| 2021 FY | 1.61 Billion USD | 19.17% |
| 2020 Q1 | 1.62 Billion USD | 3.1% |
| 2020 FY | 1.35 Billion USD | -14.44% |
| 2020 Q4 | 1.35 Billion USD | -8.22% |
| 2020 Q3 | 1.47 Billion USD | -2.9% |
| 2020 Q2 | 1.51 Billion USD | -6.88% |
| 2019 Q2 | 1.3 Billion USD | 5.86% |
| 2019 FY | 1.57 Billion USD | 35.42% |
| 2019 Q3 | 1.56 Billion USD | 20.46% |
| 2019 Q4 | 1.57 Billion USD | 0.83% |
| 2019 Q1 | 1.22 Billion USD | 5.32% |
| 2018 FY | 1.16 Billion USD | 8.16% |
| 2018 Q1 | 1.11 Billion USD | 3.25% |
| 2018 Q2 | 1.08 Billion USD | -2.34% |
| 2018 Q3 | 1.13 Billion USD | 4.32% |
| 2018 Q4 | 1.16 Billion USD | 2.82% |
| 2017 Q3 | 1.07 Billion USD | 5.28% |
| 2017 FY | 1.07 Billion USD | 12.88% |
| 2017 Q4 | 1.07 Billion USD | 0.09% |
| 2017 Q2 | 1.02 Billion USD | 5.36% |
| 2017 Q1 | 971 Million USD | 1.68% |
| 2016 Q1 | 1.02 Billion USD | 0.59% |
| 2016 FY | 955 Million USD | -6.0% |
| 2016 Q3 | 998 Million USD | 1.73% |
| 2016 Q2 | 981 Million USD | -4.01% |
| 2016 Q4 | 955 Million USD | -4.31% |
| 2015 Q3 | 1.08 Billion USD | 12.19% |
| 2015 Q4 | 1.01 Billion USD | -6.45% |
| 2015 FY | 1.01 Billion USD | 7.4% |
| 2015 Q1 | 958 Million USD | 1.27% |
| 2015 Q2 | 968 Million USD | 1.04% |
| 2014 Q4 | 946 Million USD | -4.35% |
| 2014 Q2 | 949 Million USD | 2.48% |
| 2014 Q3 | 989 Million USD | 4.21% |
| 2014 FY | 946 Million USD | 5.46% |
| 2014 Q1 | 926 Million USD | 3.23% |
| 2013 Q1 | 851 Million USD | -3.73% |
| 2013 Q4 | 897 Million USD | 0.22% |
| 2013 Q3 | 895 Million USD | 6.29% |
| 2013 Q2 | 842 Million USD | -1.06% |
| 2013 FY | 897 Million USD | 1.47% |
| 2012 Q3 | 911 Million USD | 1.45% |
| 2012 Q2 | 898 Million USD | 1.01% |
| 2012 Q1 | 889 Million USD | -4.51% |
| 2012 FY | 884 Million USD | -5.05% |
| 2012 Q4 | 884 Million USD | -2.96% |
| 2011 Q1 | 899 Million USD | 0.56% |
| 2011 FY | 931 Million USD | 4.14% |
| 2011 Q4 | 931 Million USD | -4.22% |
| 2011 Q3 | 972 Million USD | 4.85% |
| 2011 Q2 | 927 Million USD | 3.11% |
| 2010 Q3 | 923 Million USD | 4.29% |
| 2010 Q2 | 885 Million USD | -2.32% |
| 2010 Q1 | 906 Million USD | -1.52% |
| 2010 FY | 894 Million USD | -2.83% |
| 2010 Q4 | 894 Million USD | -3.14% |
| 2009 Q2 | 878 Million USD | 3.05% |
| 2009 Q4 | 920 Million USD | -2.34% |
| 2009 FY | 920 Million USD | 7.85% |
| 2009 Q3 | 942 Million USD | 7.29% |
| 2009 Q1 | 852 Million USD | -0.12% |
| 2008 Q4 | 853 Million USD | -0.12% |
| 2008 FY | 853 Million USD | 17.66% |
| 2008 Q1 | 781 Million USD | 7.72% |
| 2008 Q2 | 812 Million USD | 3.97% |
| 2008 Q3 | 854 Million USD | 5.17% |
| 2007 FY | 725 Million USD | -3.2% |
| 2007 Q4 | 725 Million USD | -10.93% |
| 2007 Q1 | 793 Million USD | 5.87% |
| 2007 Q2 | 837 Million USD | 5.55% |
| 2007 Q3 | 814 Million USD | -2.75% |
| 2006 FY | 749 Million USD | 79.19% |
| 2006 Q1 | 407 Million USD | -2.63% |
| 2006 Q2 | 797 Million USD | 95.82% |
| 2006 Q3 | 759 Million USD | -4.77% |
| 2006 Q4 | 749 Million USD | -1.32% |
| 2005 Q1 | 387 Million USD | 7.5% |
| 2005 Q3 | 428 Million USD | 4.39% |
| 2005 Q2 | 410 Million USD | 5.94% |
| 2005 Q4 | 418 Million USD | -2.34% |
| 2005 FY | 418 Million USD | 16.11% |
| 2004 Q1 | 302 Million USD | 7.47% |
| 2004 FY | 360 Million USD | 28.11% |
| 2004 Q3 | 314 Million USD | 12.54% |
| 2004 Q4 | 360 Million USD | 14.65% |
| 2004 Q2 | 279 Million USD | -7.62% |
| 2003 Q2 | 239 Million USD | -0.83% |
| 2003 FY | 281 Million USD | 15.64% |
| 2003 Q3 | 247 Million USD | 3.35% |
| 2003 Q4 | 281 Million USD | 13.77% |
| 2003 Q1 | 241 Million USD | -0.82% |
| 2002 Q3 | 257 Million USD | -9.19% |
| 2002 Q4 | 243 Million USD | -5.45% |
| 2002 Q1 | 292 Million USD | -3.63% |
| 2002 Q2 | 283 Million USD | -3.08% |
| 2002 FY | 243 Million USD | -19.8% |
| 2001 Q2 | 319 Million USD | -11.63% |
| 2001 Q1 | 361 Million USD | 1.98% |
| 2001 Q3 | 324 Million USD | 1.57% |
| 2001 Q4 | 303 Million USD | -6.48% |
| 2001 FY | 303 Million USD | -14.41% |
| 2000 FY | 354 Million USD | -5.85% |
| 2000 Q2 | 334 Million USD | -5.92% |
| 2000 Q1 | 355 Million USD | -5.59% |
| 2000 Q4 | 354 Million USD | 8.26% |
| 2000 Q3 | 327 Million USD | -2.1% |
| 1999 Q1 | 463 Million USD | 0.22% |
| 1999 Q3 | 414 Million USD | -9.21% |
| 1999 Q4 | 376 Million USD | -9.18% |
| 1999 FY | 376 Million USD | -18.61% |
| 1999 Q2 | 456 Million USD | -1.51% |
| 1998 Q4 | 462 Million USD | -6.06% |
| 1998 FY | 462 Million USD | 19.47% |
| 1998 Q1 | 432.4 Million USD | 11.82% |
| 1998 Q2 | 459.9 Million USD | 6.36% |
| 1998 Q3 | 491.8 Million USD | 6.94% |
| 1997 Q3 | 363 Million USD | 18.4% |
| 1997 Q4 | 386.7 Million USD | 6.53% |
| 1997 FY | 386.7 Million USD | 70.95% |
| 1997 Q1 | 253.7 Million USD | 12.16% |
| 1997 Q2 | 306.6 Million USD | 20.85% |
| 1996 Q4 | 226.2 Million USD | 7.82% |
| 1996 FY | 226.2 Million USD | 56.0% |
| 1996 Q1 | 169.4 Million USD | 16.83% |
| 1996 Q2 | 190.3 Million USD | 12.34% |
| 1996 Q3 | 209.8 Million USD | 10.25% |
| 1995 Q4 | 145 Million USD | 38.23% |
| 1995 Q3 | 104.9 Million USD | 8.82% |
| 1995 Q2 | 96.4 Million USD | 12.22% |
| 1995 FY | 145 Million USD | 165.08% |
| 1995 Q1 | 85.9 Million USD | 57.04% |
| 1994 FY | 54.7 Million USD | 30.86% |
| 1994 Q4 | 54.7 Million USD | 7.89% |
| 1994 Q3 | 50.7 Million USD | 9.27% |
| 1994 Q2 | 46.4 Million USD | 6.18% |
| 1994 Q1 | 43.7 Million USD | 4.55% |
| 1993 Q1 | 41.8 Million USD | 3.21% |
| 1993 Q2 | 42.4 Million USD | 1.44% |
| 1993 FY | 41.8 Million USD | 3.21% |
| 1993 Q4 | 41.8 Million USD | -5.0% |
| 1993 Q3 | 44 Million USD | 3.77% |
| 1992 Q1 | 36.8 Million USD | 1.94% |
| 1992 Q3 | 39.7 Million USD | 0.76% |
| 1992 Q4 | 40.5 Million USD | 2.02% |
| 1992 FY | 40.5 Million USD | 12.19% |
| 1992 Q2 | 39.4 Million USD | 7.07% |
| 1991 Q4 | 36.1 Million USD | 0.0% |
| 1991 FY | 36.1 Million USD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| aap Implantate AG | 4.51 Million EUR | -54880.08% |
| Drägerwerk AG & Co. KGaA | 657.88 Million EUR | -277.571% |
| Drägerwerk AG & Co. KGaA | 657.88 Million EUR | -277.571% |
| elexxion AG | 377.80 EUR | -657490635.839% |
| Eckert & Ziegler Strahlen- und Medizintechnik AG | 39.93 Million EUR | -6120.263% |
| Geratherm Medical AG | 9.39 Million EUR | -26350.846% |
| Koninklijke Philips N.V. | 3.49 Billion EUR | 28.846% |
| Stratec SE | 142.62 Million EUR | -1641.63% |
| Siemens Healthineers AG | 4.26 Billion EUR | 41.704% |